Christoph Bidlingmaier Selected Research

Christoph Bidlingmaier Research Topics

8	Hemophilia A (Haemophilia) 06/2021 - 07/2007
7	Hemorrhage 06/2021 - 01/2006
5	Thrombosis (Thrombus) 12/2020 - 12/2006
2	Thromboembolism 10/2011 - 06/2010
1	COVID-19 06/2021
1	Hematoma 06/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Thrombotic Microangiopathies 12/2020
1	Stroke (Strokes) 06/2020
1	Obesity 11/2019
1	hereditary Thrombophilia 01/2016
1	May-Thurner Syndrome 01/2016
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2010
1	Campomelic Dysplasia 06/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2006
1	Thrombocytopenia (Thrombopenia) 01/2006

4	Factor VIII (Coagulation Factor VIII)IBA 06/2021 - 11/2019
3	emicizumabIBA 06/2021 - 02/2020
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2016 - 12/2006
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2011 - 12/2006
2	Prothrombin (Factor II)IBA 12/2020 - 07/2007
1	COVID-19 VaccinesIBA 06/2021
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 06/2021
1	VaccinesIBA 06/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	AntithrombinsIBA 01/2016
1	Factor V (Coagulation Factor V)IBA 04/2014
1	histidine-rich proteinsIBA 06/2010
1	SteroidsIBA 06/2010
1	Asparaginase (Elspar)FDA Link 06/2010
1	DNA (Deoxyribonucleic Acid)IBA 06/2010
1	factor V LeidenIBA 07/2007
1	Factor Xa (Coagulation Factor Xa)IBA 12/2006
1	Heparin (Liquaemin)FDA LinkGeneric 01/2006

8	Therapeutics 06/2021 - 01/2006
1	Intramuscular Injections 06/2021
1	Thrombectomy 06/2020
1	Patient Transfer (Patient Dumping) 02/2020
1	Catheters 01/2016
1	Tonsillectomy 01/2013
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2006